Your dog was diagnosed with Dermal / Subcutaneous Hemangiosarcoma. Dermal HSA (actinic / solar-induced) occurs in lightly pigmented, short-haired dogs on ventral abdomen and prepuce. Biologically less aggressive than visceral HSA. Subcutaneous HSA has intermediate behaviour — worse than dermal, better than splenic. Compare 2 treatment options for dogs including Wide Surgical Excision (Dermal HSA), Wide Excision + Adjuvant Doxorubicin (Subcutaneous HSA) — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Dermal / Subcutaneous Hemangiosarcoma
Canine Oncology Treatment Guide
Dermal / Subcutaneous Hemangiosarcoma
Mesenchymal
About This Cancer
Hemangiosarcoma of the skin and tissues just beneath it has a notably different behaviour from the visceral (organ-based) forms of this cancer. Dermal hemangiosarcoma, found in the outermost layer of skin, is often caused by chronic sun exposure (ultraviolet radiation) and tends to occur on the thinly haired ventral abdomen of light-skinned dogs. This sun-induced form generally carries a better prognosis because it is caught earlier and is less likely to spread internally. Subcutaneous hemangiosarcoma, found in the fatty tissue beneath the skin, behaves more aggressively — intermediate between dermal and visceral forms. Short-haired, lightly pigmented breeds such as Whippets, Greyhounds, and Dalmatians are most at risk for the sun-induced variant.
Prognostic Factors(2)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.